Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

NCT05498974 is registered in ClinicalTrials.gov with Second Xiangya Hospital of Central South University as lead sponsor.

NCT NCT05498974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05498974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Lead sponsor
Second Xiangya Hospital of Central South University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
December 31, 2035
Enrollment
20,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, type1diabetes